Taste Loss From a Breakthrough Myeloma Drug May Push Patients to Quit Therapy
A cross-sectional study of 32 multiple myeloma patients found that talquetamab caused taste disturbances in every participant, with impaired taste ...
Tag: GPRC5D
Talquetamab vs. Physician’s Choice in Relapsed Myeloma
In recent years, the landscape of multiple myeloma treatment has become increasingly complex, particularly among patients who have already been ...
POPULAR NEWS
-
Imaging Reveals Human Pericyte Fate in Mouse Muscle
-
Water Exchange Rates Reshape Microbiome Dynamics and Ivory Shell Survival in Aquaculture
-
Pediatric Sitosterolemia Cases Reveal Lipid Disorder Mimicking Childhood Rheumatic Joint Disease
-
Dual Bacillus Probiotic Yields Softer Stool and Targeted Immune Shifts in Dogs